DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

Abstract Background The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program. The aims of the study were to measure 1) antibody persistence 12–18 months after a primary serie...

Full description

Bibliographic Details
Main Authors: Hartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, Soedjatmiko, Meita Dhamayanti, Rini Sekartini, Rodman Tarigan, Hindra Irawan Satari, Bernie Endyarni Medise, Rini Mulia Sari, Novilia Sjafri Bachtiar, Cissy B. Kartasasmita, Sri Rezeki S. Hadinegoro
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Pediatrics
Subjects:
Booster dose
DTwP-HB-Hib vaccine
Immunogenicity
Safety
Children
Online Access:http://link.springer.com/article/10.1186/s12887-018-1143-6

Internet

http://link.springer.com/article/10.1186/s12887-018-1143-6

Similar Items